Empirical Antibiotic Monotherapy for Febrile Neutropenia In “Empirical Antibiotic Monotherapy for Febrile Neutropenia ” Mical et al explore treatment options for febrile neutropenia . They admit the standard treatment for febrile neutropenia is a broad-spectrum anti-biotic. However, there are also a number of monotherapy options involving B- lactams . The authors want to know whether patient outcomes were influenced by the type of B- lactams used in monotherapy treatments( Mical et al, 2006, p.176). To do this the authors did a systematic review and meta-analysis of randomized controlled trials( Mical et al, 2006, p.176). In other words they were doing a literature review of various trials involving the use of B- lactams for febrile...The end:
.....eatment of febrile neutropenia ( Mical et al, 2006, p.176). They also make reasonable recommendations for the use of the remaining B- lactams . For example, they don’t eliminate the possibility of using Cefepime outright. Instead they suggest that further study is required regarding the use of Cefepime ( Mical et al, 2006, p.176). What conclusions like this they are suggesting that for the time being there are some B- lactams that should be used and some that need to be reexamined. References Mical , Paul, Yahav , Dafna , Fraser, Abigail and Leibovici.2006. Empirical Antibiotic Monotherapy for Febrile Neutropenia . Journal of Antimicrobial Chemotherapy.57: 176-189. P Value.2010. P Value. Answers.com: http://www.answers.com/ topic/p-value-2.